Clinical trial
HemoSphere Alta Clinical Development Study
NCT07148323 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HemoSphere Alta Clinical Development Study
- Lead sponsor
- Becton, Dickinson and Company
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 14, 2025
- Completion date
- December 31, 2026
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemodynamic instability